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ABSTRACT
Histoplasmosis is a systemic fungal disease, also known as Darling’s disease, caused by the dimorphic fun-
gus Histoplasma capsulatum. It is usually self-limiting or localized in immunecompetent individuals whereas 
in patients with acquired immune deficiency syndrome (AIDS), it occurs in the disseminated form in 95% 
of cases. Although histoplasmosis predominates in the Americas (United States and Latin America, includ-
ing Brazil) as an important infection among AIDS patients, it is not common in Bangladesh. In contrast, 
tuberculosis is extremely common in Bangladesh, with an estimated prevalence of 387 per 100,000 people. 
Here, a confirmed case of disseminated histoplasmosis is reported in Bangladesh in a known HIV-positive 
patient, which was initially suspected to be extrapulmonary tuberculosis. 
Key words: Case studies; Histoplasma capsulatum; Histoplasmosis; HIV; Tuberculosis; Bangladesh
Correspondence and reprint requests should be 
addressed to: 
Dr. Md. Moshtaq Pervez








Histoplasmosis is a granulomatous fungal disease 
caused by Histoplasma capsulatum found in soil rich 
in excreta of bats and birds. This disease has variable 
clinical features. Upper airway or digestive tract le-
sions are chiefly associated with systemic disease, 
especially affecting patients with immune suppres-
sion, as in human immunodeficiency virus (HIV) 
infection. Disseminated disease usually occurs in 
immunecompromised patients or in patients with 
chronic illness (1). In the setting of disseminated 
disease, oral lesions are present in 30-50% of pa-
tients and may occur in almost every part of the 
oral mucosa (2). Here, we are reporting a case of 
histoplasmosis manifesting with dermatologic, 
oral, and lymph-node lesions in the context of ad-
vanced HIV disease. 
CASE REPORT
A 32-year-old HIV-positive male, a storekeeper of 
a chemical company, from an eastern division of 
Bangladesh, was admitted to the Jagori ward (HIV 
inpatient unit) of the Dhaka Hospital, ICDDR,B, 
on 24 November 2009, with a six-month history of 
fever, loss of appetite, oral discomfort, weight loss 
(>20 kg), and multiple papular eruptions over the 
face and upper limbs. He had been diagnosed HIV-
positive five months ago, shortly after presenting 
to another healthcare facility with the above symp-
toms and giving history of previous multiple con-
tacts with commercial sex workers (CSWs). His CD4 
count at that time was 19 cells per µL. In view of the 
low CD4 count, the patient was started on highly-
active antiretroviral therapy (HAART) while investi-
gations were ongoing. Subsequently, a lymph-node 
biopsy was performed from the left supraclavicu-
lar lymph-node, and histopathology examination 
demonstrated multiple lymphocytes, clusters of epi-
theloid histiocytes, and caseous necrotic material. 
The histopathological report suggested granuloma-
tous lymphadenitis and mycobacterial tuberculosis 
infection as the most likely diagnosis. Considering 
that tuberculosis is the commonest cause of pyrexia Pervez MM et al. Disseminated histoplasmosis—lessons learnt
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of unknown origin (PUO) in Bangladesh and in the 
context of histopathological report, this patient was 
started on anti-tubercular therapy (ATT). However, 
after three months of ATT, as his clinical condition 
did not improve, he was referred to the Jagori ward 
for specialist input. 
At admission, the patient was emaciated and febrile 
(39.6 ºC). Extensive oral thrush, multiple mouth-
ulcers, and sloughing of the buccal mucosa were 
noted. Multiple ulcers were also noted in the na-
sopharynx with occasional bleeding points. A large 
lymph-node over anterior triangle of the left side 
of the neck was found which was firm, non-tender, 
and mobile. Dermatologic examination revealed 
multiple papular eruptions over the face and upper 
limbs, which were non-tender and non-itchy, some 
demonstrating spontaneous ulceration and crust-
ing. Abdominal examination revealed mild, firm, 
non-tender splenomegaly. The rest of the general 
physical examination was normal. The examina-
tion of the cardiovascular, respiratory, and neuro-
logical system was unremarkable. 
Laboratory evaluation showed low haemoglobin 
of 9.6 g/dL but total white cell and platelet counts 
were within normal limits. Venereal Disease Re-
search Laboratory (VDRL) test was non-reactive. 
Liver function and renal function tests were within 
normal limits. Blood culture was negative. Chest 
X-ray was unremarkable. Endoscopy of the upper 
gastrointestinal tract showed candidiasis with mu-
cosal erosion of the esophagus. Ultrasonography of 
the abdomen showed mild splenomegaly (3.5 cm) 
with no focal lesions and a normal liver. 
Tuberculosis-HIV co-infection is very common but 
the patient’s non-response to ATT suggested an 
alternative diagnosis. The clinical feature of papu-
lar lesions associated with a systemic illness in an 
HIV-infected individual was more suggestive of a 
disseminated fungal infection. Therefore, lymph-
node biopsy from the left side of the neck was re-
peated. The report stated “necrotic material mixed 
with polymorphs, lymphocytes and histiocytes. On 
Gomori’s Methenamine Silver stain, there are yeast-
like bodies present extracellularly as well as within 
the histiocytes.” Histopathologists concluded that 
the abscess associated with deep fungal infection 
was morphologically consistent with histoplasmo-
sis. A diagnosis of disseminated histoplasmosis was 
made, and the patient was commenced on intra-
venous (IV) amphotericin B (0.7 mg/kg/day), as 
per the Bangladesh national guideline on manage-
ment of opportunistic infections (3), and his clini-
cal condition improved dramatically within one 
week of treatment. Amphotericin B was continued 
for 21 days, and the patient was then switched over 
to oral itraconazole 200 mg twice daily. 
DISCUSSION
H. capsulatum is a dimorphic fungus, an intrac-
ellular organism, which parasitizes the reticu-
loendothelial system in histoplasmosis involving 
the spleen, liver, kidney, central nervous system, 
and other organs (1). The organism exists as a 
saprophyte in nature and has been isolated 
from soil, most often when contaminated with 
chicken-feathers or droppings. Its spores are 
infectious to humans by the airborne route.   
In 95% of the cases, infection with Histoplasma is 
asymptomatic. In immunocompetent patients, it 
usually manifests as self-limiting respiratory infec-
tion comprising fever, malaise, cough, and chest-
pain. Most cases of histoplasmosis in patients with 
AIDS have been of the disseminated type. In such 
cases, patients present with prolonged fever, weight 
loss, mucocutaneous lesions, hepatosplenomegaly, 
lymphadenopathy, pneumonia, adrenal insuffi-
ciency, occasional intestinal ulcerative lesion, and, 
in some, with a sepsis-like illness (1,4). Histopatho-
logy may demonstrate granuloma formation, as in 
tuberculosis and in other fungal infections; fungal 
stains of biopsied tissue demonstrate yeast-like 
structures in about half of cases (5). 
In developing countries, tuberculosis is the com-
monest cause of granuloma formation and with 
suggestive clinical presentation; patients are often 
started on ATT as it occurred in this case. The fact 
that the patient worsened clinically while on ATT 
raised the suspicion of an alternative diagnosis.
There are important lessons to be learnt from this 
case, particularly for physicians caring for patients 
with HIV. Tuberculosis is certainly an important 
consideration in the context of its high prevalence 
in Bangladesh (6). However, in the context of HIV-
associated disease, especially as the level of immu-
nosuppression increases, it is important to consider 
wider array of potential opportunistic infections. 
Disseminated fungal infections are widely reported 
in HIV-infected persons and should be included in 
this differential diagnosis. In addition to histoplas-
mosis, other disseminated mycoses to consider in-
clude cryptococcosis and penicilliosis. Diagnostic 
confusion has been reported earlier. In one report 
from Guatemala (in Central America), of the eight 
patients who had disseminated histoplasmosis with 
AIDS, diagnosed over a 10-year period, all were ini-
tially admitted with diagnosis of tuberculosis with 
AIDS (7). Pervez MM et al. Disseminated histoplasmosis—lessons learnt
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Histoplasmosis is an uncommon cause of PUO 
among HIV-infected patients in the Indian subconti-
nent where tuberculosis, especially extrapulmonary 
tuberculosis, is the leading cause (4). Despite a few 
case reports of histoplasmosis in Bangladesh (8-9), 
the presence of H. capsulatum appears common in 
the nearby East Indian states. A study in West Bengal, 
for example, showed a prevalence of skin positivi-
ty of 9.4% to histoplasmin antigen (10), and many 
cases of histoplasmosis have been reported nearby 
the Ganges river (11). There is no natural barrier or 
significant ecological difference between Bangla-
desh and West Bengal (10). Therefore, the possibil-
ity of future cases of histoplasmosis in Bangladesh 
should be borne in mind, particularly among medi-
cal teams caring for immunosuppressed patients. Pa-
tients with advanced HIV-associated disease are not 
the only population at risk for the development of 
this opportunistic infection; a recent report of dis-
seminated histoplasmosis in a patient with renal 
transplantation returning from Bangladesh (12) is 
an important illustration of such a risk.
In this case, reconsideration of a diagnosis of ex-
trapulmonary tuberculosis facilitated accurate 
discovery and successful management of dissemi-
nated histoplasmosis, a locally-uncommon and 
unexpected opportunistic infection. This serves as 
a timely reminder that medical teams caring for 
HIV-infected and other immunosuppressed pa-
tients must remain aware of conditions which may 
be otherwise uncommon in the environment of 
their patients and in the team’s experience.
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